|
Hemostasis, Thrombosis, and Vascular Biology
Citations 361-370 of 2496 total displayed.
|
Past content
(since Jan 1997):
|
Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions
- Anetta Undas, Kathleen E. Brummel-Ziedins, and Kenneth G. Mann
Blood 2007; 109: 2285-2292.
[Abstract]
[Full text]
[PDF]
Leukocytosis is a risk factor for thrombosis in essential thrombocythemia: interaction with treatment, standard risk factors, and Jak2 mutation status
- Alessandra Carobbio, Guido Finazzi, Vittoria Guerini, Orietta Spinelli, Federica Delaini, Roberto Marchioli, Giovanna Borrelli, Alessandro Rambaldi, and Tiziano Barbui
Blood 2007; 109: 2310-2313.
[Abstract]
[Full text]
[PDF]
Transplantation of vascular endothelial cells mediates the hematopoietic recovery and survival of lethally irradiated mice
- John P. Chute, Garrett G. Muramoto, Alice B. Salter, Sarah K. Meadows, Dennis W. Rickman, Benny Chen, Heather A. Himburg, and Nelson J. Chao
Blood 2007; 109: 2365-2372.
[Abstract]
[Full text]
[PDF]
 4-Integrin+ endothelium derived from primate embryonic stem cells generates primitive and definitive hematopoietic cells
- Gen Shinoda, Katsutsugu Umeda, Toshio Heike, Masato Arai, Akira Niwa, Feng Ma, Hirofumi Suemori, Hong Yuan Luo, David H. K. Chui, Ryuzo Torii, Masabumi Shibuya, Norio Nakatsuji, and Tatsutoshi Nakahata
Blood 2007; 109: 2406-2415.
[Abstract]
[Full text]
[PDF]
Vitamin K supplementation can improve stability of anticoagulation for patients with unexplained variability in response to warfarin
- Elizabeth Sconce, Peter Avery, Hilary Wynne, and Farhad Kamali
Blood 2007; 109: 2419-2423.
[Abstract]
[Full text]
[PDF]
von Willebrand factor and factor VIII are independently required to form stable occlusive thrombi in injured veins
- Anil K. Chauhan, Janka Kisucka, Colin B. Lamb, Wolfgang Bergmeier, and Denisa D. Wagner
Blood 2007; 109: 2424-2429.
[Abstract]
[Full text]
[PDF]
Variations in glycosylation of von Willebrand factor with O-linked sialylated T antigen are associated with its plasma levels
- Carina J. M. van Schooten, Cécile V. Denis, Ton Lisman, Jeroen C. J. Eikenboom, Frank W. Leebeek, Jenny Goudemand, Edith Fressinaud, H. Marijke van den Berg, Philip G. de Groot, and Peter J. Lenting
Blood 2007; 109: 2430-2437.
[Abstract]
[Full text]
[PDF]
Involvement of the fractalkine pathway in the pathogenesis of childhood hemolytic uremic syndrome
- María Victoria Ramos, Gabriela C. Fernández, Natasha Patey, Pablo Schierloh, Ramón Exeni, Irene Grimoldi, Graciela Vallejo, Christian Elías-Costa, Maria del Carmen Sasiain, Howard Trachtman, Christophe Combadière, François Proulx, and Marina S. Palermo
Blood 2007; 109: 2438-2445.
[Abstract]
[Full text]
[PDF]
Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera
- Raffaele Landolfi, Leonardo Di Gennaro, Tiziano Barbui, Valerio De Stefano, Guido Finazzi, RosaMaria Marfisi, Gianni Tognoni, and Roberto Marchioli, for the European Collaboration on Low-Dose Aspirin in Polycythemia Vera (ECLAP)
Blood 2007; 109: 2446-2452.
[Abstract]
[Full text]
[PDF]
MRP8/MRP14 impairs endothelial integrity and induces a caspase-dependent and -independent cell death program
- Dorothee Viemann, Katarzyna Barczyk, Thomas Vogl, Ute Fischer, Cord Sunderkötter, Klaus Schulze-Osthoff, and Johannes Roth
Blood 2007; 109: 2453-2460.
[Abstract]
[Full text]
[PDF]
|
|
